
Initial Report From a Swedish High-volume Transplant Center After the First Wave of the COVID-19 Pandemic
Author(s) -
Marie Felldin,
John Mackay Søfteland,
Jesper Magnusson,
Jana Ekberg,
Kristjan Karason,
Andreas Schult,
Hillevi Larsson,
Mihai Oltean,
Vanda Friman
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003436
Subject(s) - medicine , hydroxychloroquine , immunosuppression , transplantation , pediatrics , disease , covid-19 , infectious disease (medical specialty)
Solid organ transplant (SOT) recipients may be more vulnerable to coronavirus disease 2019 (COVID-19). Data on the clinical course of COVID-19 in immunosuppressed patients are limited, and the optimal management strategy for these patients is yet unclear.